What is Injective?
Injective, founded in 2018 and based in New York, NY, operates as a prominent smart contracts platform provider. The company is strategically focused on the development and deployment of decentralized finance (DeFi) applications, aiming to enhance the efficiency and accessibility of financial services within the blockchain ecosystem. Its technological infrastructure is designed to support a new generation of financial instruments and platforms.
How much funding has Injective raised?
Injective has raised a total of $190M across 2 funding rounds:
Series C
$40M
Series D
$150M
Series C (2022): $40M with participation from Jump Crypto
Series D (2023): $150M led by Kraken Ventures and Pantera Capital
Key Investors in Injective
Kraken Ventures
Kraken Ventures is an independent investment fund targeting early stage companies and protocols across the crypto and fintech ecosystem. The fund invests in the technologies powering the next wave of crypto and fintech innovation, providing entrepreneurs with the resources and industry expertise they need to build and scale their business.
Pantera Capital
Pantera Capital is a blockchain focused investment firm that backs founders and digital asset networks, combining venture and hedge strategies to give investors broad exposure to cryptocurrencies, token projects and companies shaping future financial infrastructure.
Jump Crypto
Undisclosed investor participating in the funding round.
What's next for Injective?
The substantial enterprise-level funding and recent strategic investment indicate that Injective is poised for significant scaling and further innovation. This capital infusion is likely to accelerate product development, expand market reach, and strengthen its competitive advantage in the rapidly evolving DeFi sector. The company's focus on decentralized finance applications suggests a strategic push towards building robust and secure financial infrastructure for the future.
See full Injective company page
